Carregant...
Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study
INTRODUCTION: Since just after the year 2000 in Quebec, the management of metastatic castration-resistant prostate cancer (mcrpc) has evolved considerably, with the inclusion of docetaxel-based chemotherapy, bone-targeted therapies (zoledronic acid and denosumab), and more recently, abiraterone, enz...
Guardat en:
| Publicat a: | Curr Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576460/ https://ncbi.nlm.nih.gov/pubmed/28874892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3598 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|